For help on how to get the results you want, see our search tips.
1466 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Dasselta (updated)
desloratadine, Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Seasonal, Urticaria
Date of authorisation: 28/11/2011,
, Revision: 11, Authorised, Last updated: 29/05/2020
-
List item
Human medicine European public assessment report (EPAR): Mvasi (updated)
bevacizumab, Carcinoma, Renal Cell, Peritoneal Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms
Date of authorisation: 15/01/2018,
, 
, Revision: 7, Authorised, Last updated: 29/05/2020
-
List item
Human medicine European public assessment report (EPAR): Fabrazyme (updated)
agalsidase beta, Fabry Disease
Date of authorisation: 03/08/2001, Revision: 28, Authorised, Last updated: 29/05/2020 -
List item
Human medicine European public assessment report (EPAR): Remsima (updated)
infliximab, Arthritis, Psoriatic, Spondylitis, Ankylosing, Colitis, Ulcerative, Psoriasis, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 10/09/2013,, Revision: 19, Authorised, Last updated: 29/05/2020
-
List item
Human medicine European public assessment report (EPAR): INOmax (updated)
Nitric oxide, Hypertension, Pulmonary, Respiratory Insufficiency
Date of authorisation: 01/08/2001, Revision: 21, Authorised, Last updated: 29/05/2020 -
List item
Human medicine European public assessment report (EPAR): Lorviqua (updated)
Lorlatinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 06/05/2019,, 
, Revision: 2, Authorised, Last updated: 29/05/2020
-
List item
Human medicine European public assessment report (EPAR): Dexdor (updated)
dexmedetomidine hydrochloride, Conscious Sedation
Date of authorisation: 15/09/2011, Revision: 13, Authorised, Last updated: 29/05/2020 -
List item
Human medicine European public assessment report (EPAR): Baraclude (updated)
Entecavir, Hepatitis B, Chronic
Date of authorisation: 26/06/2006, Revision: 26, Authorised, Last updated: 28/05/2020 -
List item
Human medicine European public assessment report (EPAR): Bydureon (updated)
exenatide, Diabetes Mellitus, Type 2
Date of authorisation: 17/06/2011, Revision: 20, Authorised, Last updated: 28/05/2020 -
List item
Human medicine European public assessment report (EPAR): Myalepta (updated)
Metreleptin, Lipodystrophy, Familial Partial
Date of authorisation: 29/07/2018,, 
, 
, Revision: 3, Authorised, Last updated: 28/05/2020
-
List item
Human medicine European public assessment report (EPAR): Nubeqa (updated)
darolutamide, Prostatic Neoplasms, Castration-Resistant
Date of authorisation: 27/03/2020,, Revision: 1, Authorised, Last updated: 28/05/2020
-
List item
Human medicine European public assessment report (EPAR): Kineret (updated)
anakinra, Arthritis, Rheumatoid
Date of authorisation: 08/03/2002, Revision: 26, Authorised, Last updated: 28/05/2020 -
List item
Human medicine European public assessment report (EPAR): CoAprovel (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 14/10/1998, Revision: 39, Authorised, Last updated: 28/05/2020 -
List item
Human medicine European public assessment report (EPAR): HyQvia (updated)
Human normal immunoglobulin, Immunologic Deficiency Syndromes
Date of authorisation: 16/05/2013,, Revision: 14, Authorised, Last updated: 28/05/2020
-
List item
Human medicine European public assessment report (EPAR): Lynparza (updated)
Olaparib, Ovarian Neoplasms
Date of authorisation: 16/12/2014, Revision: 9, Authorised, Last updated: 28/05/2020 -
List item
Human medicine European public assessment report (EPAR): Bridion (updated)
sugammadex, Neuromuscular Blockade
Date of authorisation: 25/07/2008, Revision: 16, Authorised, Last updated: 27/05/2020 -
List item
Human medicine European public assessment report (EPAR): Fycompa (updated)
perampanel, Epilepsies, Partial
Date of authorisation: 23/07/2012, Revision: 17, Authorised, Last updated: 27/05/2020 -
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, , Revision: 2, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Imvanex (updated)
modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus, Smallpox Vaccine
Date of authorisation: 31/07/2013,, , Revision: 15, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Fulvestrant Mylan (updated)
fulvestrant, Breast Neoplasms
Date of authorisation: 08/01/2018,, Revision: 2, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Olanzapine Teva (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007,, Revision: 27, Authorised, Last updated: 27/05/2020
-
List item
Human medicine European public assessment report (EPAR): Jardiance (updated)
empagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 22/05/2014, Revision: 18, Authorised, Last updated: 26/05/2020 -
List item
Human medicine European public assessment report (EPAR): ellaOne (updated)
ulipristal, Contraception, Postcoital
Date of authorisation: 15/05/2009, Revision: 21, Authorised, Last updated: 26/05/2020 -
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
irinotecan hydrochloride trihydrate, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,, Revision: 5, Authorised, Last updated: 25/05/2020
-
List item
Human medicine European public assessment report (EPAR): Brintellix (updated)
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 14, Authorised, Last updated: 25/05/2020